Literature DB >> 2185935

Insulin therapy on the peritoneal route: effects on glucose control in experimental insulin dependent diabetes.

U Fischer1, K Fritze, E J Freyse.   

Abstract

To quantitate the degree of glycemic control in relation to insulin doses required on the peritoneal route of administration, insulin dependent diabetic dogs instrumented with chronic peritoneal and venous catheters and with access devices for serial peritoneal injections, were treated with regular insulin at random order as follows: (1) subcutaneous injections, (2) peritoneal injections, (3) continuous intravenous infusion, (4) continuous peritoneal infusion. Metabolic profiles were taken over 24 h after an average duration of treatment of 2 weeks and were compared to data obtained in nondiabetic animals. Insulin doses and postprandial increase in peripheral insulinemia were higher and glycemic control was worse on peritoneal vs. subcutaneous injection therapy. Glycemic control and insulin doses were identical between peritoneal and intravenous infusion regimes. Hyperinsulinemia was only seen during nighttime in intravenously infused animals. It is concluded that in accordance with the fast pharmacokinetics of peritoneally administered insulin, sufficient glycemic and insulinemic control can only be obtained on the peritoneal route, when the insulin is applied by means of pumps.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185935     DOI: 10.1055/s-0029-1210929

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  2 in total

1.  Differences in protein and energy metabolism following portal versus systemic administration of insulin in diabetic dogs.

Authors:  E-J Freyse; U Fischer; S Knospe; G C Ford; K S Nair
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

2.  Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels.

Authors:  Ilze Dirnena-Fusini; Marte Kierulf Åm; Anders Lyngvi Fougner; Sven Magnus Carlsen; Sverre Christian Christiansen
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.